Targeting fibroblast growth factor pathways in prostate cancer.
about
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesPrognostic Significance and Functional Role of CEP57 in Prostate CancerDifferential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Overexpression of FGF9 in prostate epithelial cells augments reactive stroma formation and promotes prostate cancer progression.SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.Type 2 Fibroblast Growth Factor Receptor Signaling Preserves Stemness and Prevents Differentiation of Prostate Stem Cells from the Basal Compartment.Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasisFGF23 promotes prostate cancer progression.A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.Cell surface localization of importin α1/KPNA2 affects cancer cell proliferation by regulating FGF1 signalling.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.New therapeutic targets for cancer bone metastasisProstate organogenesis: tissue induction, hormonal regulation and cell type specification.Emerging roles of FGF signaling in hepatocellular carcinoma.A critical question for cancer therapy: what new targets exist?SNP-SNP interactions as risk factors for aggressive prostate cancer.Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN.Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators.Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cellsFGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells
P2860
Q28247245-2D4C28FA-DEB0-423E-8B06-202C3C007377Q30361019-B715A128-CEF9-482A-9F2C-9C071E827C70Q33781661-ABCCE43A-37CA-470B-8380-3C2C227A9041Q34699785-FE18E893-FD93-4E20-80E2-4E9BDAB844C4Q35830052-91375B9A-D5F3-4E14-9643-8127DD4E1B58Q35833703-CD4ECB9A-BFC1-4748-A0AD-A6643E153E8FQ35859471-BA287576-A9E8-4D7D-875C-DBABF38ED149Q35952716-C0B42148-833E-4AD3-B23F-7E1B7C0A0492Q36232035-A9923C1D-0762-4DAA-ABE8-FBC52C819A46Q36385066-0ADF25B4-E4E3-4DD3-928A-EDF12D642FC7Q36462972-CEA8E062-A366-4E29-90DA-546663333EBFQ36591378-889DB137-D732-4222-A530-5237C834128AQ37615017-A3161CD4-51A8-4FF6-97AE-EE51424A1AE4Q37701569-5200503C-25F1-4B86-8F86-0D2C6FFFDFFEQ38473066-DCDAC5B9-92B1-479C-876A-B0D9E55EB8E1Q39235902-ED2EBAE9-C157-4912-AE54-8AC211326C95Q41876265-CC214F56-3119-4F24-8659-B9E525A700CCQ41940514-F4BB571C-7136-410A-9F72-71313FC59DBEQ42054665-6A48A8E6-C31E-4B12-BBC8-87DD210B284DQ42240146-549AA091-864D-4023-8F12-71A281F6360AQ49997063-DD0AE752-B07E-4ABB-AF98-64C51BC47F0AQ52723926-714B4911-694B-4DD2-A2DB-F73C92C7EC1FQ52726553-896ECF19-439E-416F-A934-4388BA63FA10Q54111821-1D58649C-E17C-498D-A33D-42ABB810AF27Q55332470-5838EB97-69A9-4872-B0FF-E9C370A0AA30Q58572503-0CEEF7C9-79C1-470F-B6A5-E94673A7D86AQ58713781-28B0336C-A45D-4622-A643-46754B866FD6
P2860
Targeting fibroblast growth factor pathways in prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Targeting fibroblast growth factor pathways in prostate cancer.
@en
type
label
Targeting fibroblast growth factor pathways in prostate cancer.
@en
prefLabel
Targeting fibroblast growth factor pathways in prostate cancer.
@en
P2093
P2860
P1476
Targeting fibroblast growth factor pathways in prostate cancer.
@en
P2093
Nora Navone
Paul G Corn
Wallace L McKeehan
P2860
P304
P356
10.1158/1078-0432.CCR-13-1550
P407
P577
2013-09-19T00:00:00Z